CAMBRIDGE, Mass.–(BUSINESS WIRE)–Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it received a score of 100 on the Human Rights Campaign Foundation’s 2021 Corporate Equality Index (CEI), the nation’s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ workplace equality. This is the third consecutive year in which Philips has been named to this prestigious list – and the first time scoring 100% – recognizing the company’s relentless focus on diversity, equity and inclusion.
The CEI rates hundreds of publicly and privately held mid- to large-sized businesses on detailed criteria falling under four central pillars: non-discrimination policies across business entities, equitable benefits for LGBTQ workers and their families, supporting an inclusive culture and corporate social responsibility. Philips efforts in satisfying all of the CEI’s criteria earned a 100% ranking and the designation as one of the Best Places to Work for LGBTQ Equality.
“It has been an incredible journey focused on continuous improvements based upon each year’s results to achieve CEI’s designation as a ‘Best Place to Work for LGBTQ Equality,’” said Lauren Gohde, Philips North America Inclusion & Diversity Lead. “Our result is an incredible proof point of the power of cross departmental collaboration focused on achieving a mutual goal. We are very proud of our 2021 CEI recognition and remain committed to achieving a culture of inclusion and belonging for all of our employees.”
Philips has taken many steps to create a work environment that reflects society, the partners it works with and the customers it serves. The most recent initiatives further ensure support for all employees, including changes to its pension hardship distribution policy to include domestic partners, launch of a vendor non-discrimination agreement, a mobility policy update to include LGBTQ colleagues and their partners and CSR giving guidelines.
“From the previously unimaginable impact of the COVID-19 pandemic, to a long overdue reckoning with racial injustice, 2020 was an unprecedented year. Yet, many businesses across the nation stepped up and continued to prioritize and champion LGBTQ equality,” said Alphonso David, Human Rights Campaign president. “This year has shown us that tools like the CEI are crucial in the work to increase equity and inclusion in the workplace, and also that companies must breathe life into these policies and practices in real and tangible ways. Thank you to the companies that understand protecting their LGBTQ employees and consumers from discrimination is not just the right thing to do — but the best business decision.”
To read the full report, please visit www.hrc.org/cei.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Contacts
Silvie Casanova
Philips North America
781-879-0692
Silvie.casanova@philips.com
Avi Dines
Philips North America
781-690-3814
Avi.dines@philips.com
Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE)…
MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL)…
SKYSCRAPER-06 evaluating tiragolumab plus Tecentriq and chemotherapy did not meet the primary endpoints of progression-free…
ICPO Center NuMeRI ICPO Foundation signed the contract with Nuclear Medicine Research Infrastructure (NuMeRI) to…
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 04, 2024 (GLOBE NEWSWIRE) -- HUTCHMED…